P2RX7 and melanoma: Recently, it was found that P2X7 was abundantly expressed in cancer cells of leukemia, neuroblastoma, melanoma, as well as in prostate, breast and thyroid cancer [15], [16], [17], [18], [19], and was even proposed to be a biomarker for early stage cancer [17], [20], [21].